Finance Minister proposes changes in the basic customs duty on X-ray tubes and flat panel detectors’ provides ₹2,143 crore as production linked incentives for the pharmaceutical industry
The Union government has continued its emphasis on tackling non-communicable diseases, and allocating funds for research in the healthcare sector, with Finance Minister Nirmala Sitharaman on July 23 announcing customs duty exemptions on three cancer treatment drugs — Trastuzumab Deruxtecan, Osimertinib, and Durvalumab.
SOURCE – The Hindu
